RBC Capital analyst Deane Dray reiterated a Hold rating on Danaher Corp (NYSE: DHR) on July 10 and set a price target of $99. The company’s shares closed yesterday at $99.62.
According to TipRanks.com, Dray is a 4-star analyst with an average return of 5.2% and a 59.4% success rate. Dray covers the Industrial Goods sector, focusing on stocks such as Atkore International Group Inc, Emerson Electric Company, and Eaton Corporation.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Danaher Corp with a $110.17 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $104.82 and a one-year low of $78.97. Currently, Danaher Corp has an average volume of 2.24M.
Based on the recent corporate insider activity of 76 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of DHR in relation to earlier this year. Most recently, in April 2018, Linda Hefner, a Director at DHR sold 18,001 shares for a total of $1,827,102.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
